Lionco Pharmaceutical Group Co.,Ltd.

SHSE:603669 Stock Report

Market Cap: CN¥3.3b

Lionco Pharmaceutical GroupLtd Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 603669?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,876,2000.693%
Individual Insiders112,996,54316.1%
General Public246,011,31735%
Private Companies339,652,80048.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 65.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
48.3%
Zhejiang Lionco Pharmaceutical Co., Ltd.
339,652,800CN¥1.6b0%no data
6.85%
Ling Ping Tao
48,157,200CN¥227.8m0%no data
3.11%
Wen Nan Wang
21,908,600CN¥103.6m0%no data
2.79%
Xiao Dong Jiang
19,645,200CN¥92.9m0%no data
2.29%
Xiao Gang Tao
16,128,840CN¥76.3m0%no data
1.02%
Ling Gang Tao
7,156,703CN¥33.9m0%no data
0.77%
China Asset Management Co. Ltd.
5,408,800CN¥25.6m859%no data
0.18%
Zhong Ou Fund Management Co., Ltd
1,277,200CN¥6.0m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.